SenzaGen AB (SENZA.ST)

SEK 7.0

(0.0%)

Net Debt Summary of SenzaGen AB

SenzaGen AB's latest annual net debt in 2023 was -15.95 Million SEK , up 58.86% from previous year.
SenzaGen AB's latest quarterly net debt in 2024 Q2 was -38.65 Million SEK , down -286.59% from previous quarter.
SenzaGen AB reported annual net debt of -38.76 Million SEK in 2022, up 43.36% from previous year.
SenzaGen AB reported annual net debt of -68.45 Million SEK in 2021, up 23.39% from previous year.
SenzaGen AB reported quarterly net debt of -10 Million SEK for 2024 Q1, up 37.31% from previous quarter.
SenzaGen AB reported quarterly net debt of -15.95 Million SEK for 2023 Q3, up 33.58% from previous quarter.

Annual Net Debt Chart of SenzaGen AB (2023 - 2014)

Historical Annual Net Debt of SenzaGen AB (2023 - 2014)

Year	Net Debt	Net Debt Growth
2023	-15.95 Million SEK	58.86%
2022	-38.76 Million SEK	43.36%
2021	-68.45 Million SEK	23.39%
2020	-89.34 Million SEK	25.84%
2019	-120.46 Million SEK	-112.72%
2018	-56.63 Million SEK	31.55%
2017	-82.73 Million SEK	-266.43%
2016	-22.57 Million SEK	38.05%
2015	-36.44 Million SEK	-1289.93%
2014	-2.62 Million SEK	0.0%

Year	Net Debt	Net Debt Growth
2024 Q2	-38.65 Million SEK	-286.59%
2024 Q1	-10 Million SEK	37.31%
2023 Q3	-15.95 Million SEK	33.58%
2023 Q1	41.06 Million SEK	205.92%
2023 FY	-15.95 Million SEK	58.86%
2023 Q4	-15.95 Million SEK	0.0%
2023 Q2	-24.01 Million SEK	-158.49%
2022 Q3	-38.76 Million SEK	19.44%
2022 Q4	-38.76 Million SEK	0.0%
2022 FY	-38.76 Million SEK	43.36%
2022 Q2	-48.12 Million SEK	0.0%
2022 Q1	-48.12 Million SEK	29.7%
2021 Q1	-75.57 Million SEK	15.41%
2021 FY	-68.45 Million SEK	23.39%
2021 Q4	-68.45 Million SEK	0.0%
2021 Q3	-68.45 Million SEK	9.42%
2021 Q2	-75.57 Million SEK	0.0%
2020 Q3	-89.34 Million SEK	12.01%
2020 Q1	-101.53 Million SEK	15.71%
2020 Q2	-101.53 Million SEK	0.0%
2020 FY	-89.34 Million SEK	25.84%
2020 Q4	-89.34 Million SEK	0.0%
2019 Q4	-120.46 Million SEK	0.0%
2019 FY	-120.46 Million SEK	-112.72%
2019 Q2	-41.87 Million SEK	0.0%
2019 Q1	-41.87 Million SEK	26.07%
2019 Q3	-120.46 Million SEK	-187.72%
2018 Q2	-76.47 Million SEK	0.0%
2018 Q3	-56.63 Million SEK	25.94%
2018 Q4	-56.63 Million SEK	0.0%
2018 Q1	-76.47 Million SEK	7.57%
2018 FY	-56.63 Million SEK	31.55%
2017 Q3	-82.73 Million SEK	-347.13%
2017 Q4	-82.73 Million SEK	0.0%
2017 Q1	-18.5 Million SEK	18.05%
2017 Q2	-18.5 Million SEK	0.0%
2017 FY	-82.73 Million SEK	-266.43%
2016 FY	-22.57 Million SEK	38.05%
2016 Q3	-22.57 Million SEK	0.0%
2016 Q4	-22.57 Million SEK	0.0%
2016 Q1	37.94 Million SEK	0.0%
2015 FY	-36.44 Million SEK	-1289.93%
2014 FY	-2.62 Million SEK	0.0%

Peer Net Debt Comparison of SenzaGen AB

Name	Net Debt	Net Debt Difference
AroCell AB (publ)	-50.72 Million SEK	68.553%
Devyser Diagnostics AB (publ)	-188.09 Million SEK	91.52%
Immunovia AB (publ)	-72.5 Million SEK	77.999%
Prostatype Genomics AB (publ)	-2.61 Million SEK	-509.981%
Spermosens AB	5.02 Million SEK	417.433%